Poor Test–Retest Stability of Nocturnal REM Sleep Onset Markers in Narcolepsy Type 1

Clicks: 5
ID: 338686
2026
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #244 of 245 articles by views in Sleep & breathing = Schlaf & Atmung

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 245 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Abstract
STUDY OBJECTIVES: To assess the test-retest stability of nocturnal sleep-onset REM periods (nSOREMPs) in untreated patients with narcolepsy type 1 (NT1), and of nocturnal direct REM (nDREM) transitions and their clinical and biological correlates. METHODS: We included consecutive children and adults with NT1 diagnosed according to ICSD-3-TR criteria based on excessive daytime sleepiness, cataplexy, multiple sleep latency test (MSLT) findings, or CSF hypocretin-1 deficiency, without using nSOREMPs for diagnosis. All patients underwent two untreated overnight polysomnographic (PSG). nSOREMP was defined as REM sleep within 15 minutes of sleep onset, and nDREM as direct transition from wakefulness or N1 to REM sleep without intervening N2 or N3 sleep. RESULTS: Among 227 patients (108 males; mean age 31.6 years (SD=14.8)), nSOREMPs were present on both PSGs in 41.8%, on one only in 35.7%, and absent on both in 22.4%, yielding poor test-retest agreement (κ=0.26, 95% CI 0.14-0.39, McNemar test p=0.10). Persistent nSOREMPs were associated with younger age, shorter sleep latency, more SOREMPs on the MSLT, and lower hypocretin levels, but not with PSG interval, symptom severity, or medication history. nDREM was present on both PSGs in 15.9%, on one PSG in 37.4%, and absent on both in 46.7%, with poor stability and persistence associated with younger age, shorter MSLT sleep latency, and lower CSF hypocretin levels. CONCLUSIONS: nSOREMPs and nDREMs showed limited test-retest stability in untreated children and adults with NT1. Their association with age, MSLT findings, and hypocretin levels suggest variable REM dysregulation rather than stable individual traits. Absence of nSOREMP even on two PSG should not exclude NT1.
Reference Key
openalex_W7225258151 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors
Journal Sleep & breathing = Schlaf & Atmung
Year 2026
DOI
10.1093/sleep/zsag292
URL
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.